{"result": {"id": "2cf1a785-e1ae-4412-968b-57dc213df9d2", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Pediatric Hypertension Medications and Regulatory Bodies\",\n    \"summary\": \"This community is centered around medications approved for pediatric hypertension treatment and their regulatory bodies, specifically the National Medical Products Administration (NMPA) and the U.S. Food and Drug Administration (FDA). The NMPA has approved several medications, including Captopril and Fosinopril, for pediatric use, highlighting its pivotal role in the community. The relationship between the NMPA and the FDA underscores the global context of drug regulation and approval processes.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of pediatric hypertension treatment and the global regulatory oversight involved.\",\n    \"findings\": [\n        {\n            \"summary\": \"NMPA's central role in medication approval\",\n            \"explanation\": \"The National Medical Products Administration (NMPA) is a central entity in this community, having approved multiple medications for pediatric hypertension treatment. Its approvals include Captopril and Fosinopril, among others, indicating its significant influence over the availability of these treatments in the market. [Data: Entities (1208), Relationships (1540, 1541, 1542, 1543, 1546,+more)]\"\n        },\n        {\n            \"summary\": \"Diverse range of approved medications\",\n            \"explanation\": \"The community includes a diverse range of medications approved for pediatric hypertension treatment, such as ACE inhibitors like Captopril and Fosinopril, diuretics like Amiloride and Chlorthalidone, and adrenergic receptor blockers like Propranolol and Atenolol. This diversity reflects the comprehensive approach to managing pediatric hypertension. [Data: Entities (1137, 1142, 1506, 1507, 1508,+more)]\"\n        },\n        {\n            \"summary\": \"Global regulatory collaboration\",\n            \"explanation\": \"The relationship between the NMPA and the U.S. FDA highlights the importance of global collaboration in drug regulation. This connection ensures that drug approval processes and guidelines are aligned, facilitating the availability of safe and effective medications across borders. [Data: Relationships (1108)]\"\n        },\n        {\n            \"summary\": \"Focus on pediatric hypertension\",\n            \"explanation\": \"The community's focus on pediatric hypertension treatment underscores the critical need for effective and safe medications for children. The approval of multiple medications for this demographic by the NMPA indicates a concerted effort to address this need. [Data: Entities (1137, 1142, 1506, 1507, 1508,+more)]\"\n        },\n        {\n            \"summary\": \"Regulatory bodies' impact on medication availability\",\n            \"explanation\": \"The regulatory bodies, particularly the NMPA, play a crucial role in determining which medications are available for pediatric hypertension treatment. Their approvals directly impact the treatment options available to healthcare providers and patients. [Data: Entities (1208, 1209), Relationships (1540, 1541, 1542, 1543, 1546,+more)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559878, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 654, "prompt_tokens": 2617, "total_tokens": 3271, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 1145}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1137,CAPTOPRIL,\"**Captopril** is an angiotensin-converting enzyme inhibitor (ACEI) medication approved for the treatment of hypertension. It is also indicated for use in pediatric patients with hypertension. As an ACE inhibitor, captopril works by relaxing blood vessels, thereby lowering blood pressure and improving cardiovascular function. Its applications include managing high blood pressure in both adults and children.\",2\n1208,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,\"Chinese regulatory body for drugs (mentioned as reference for drug usage guidelines)\"\"\",11\n1142,FOSINOPRIL,\"Fosinopril is an angiotensin-converting enzyme inhibitor (ACEI) medication primarily used for the treatment of hypertension. It has been approved for use in pediatric patients, making it a viable option for managing high blood pressure in children. As an ACE inhibitor, Fosinopril works by relaxing blood vessels, thereby reducing blood pressure and improving cardiovascular outcomes. Its applications are consistent across both adult and pediatric populations, with a focus on hypertension management.\",2\n1209,U.S. FOOD AND DRUG ADMINISTRATION,\"U.S. regulatory body referenced for drug half-life information\"\"\",1\n1506,AMILORIDE,A diuretic medication approved for pediatric hypertension treatment,1\n1507,CHLORTHALIDONE,A diuretic medication approved for pediatric hypertension treatment,1\n1508,PROPRANOLOL,An adrenergic receptor blocker medication approved for pediatric hypertension treatment,1\n1509,ATENOLOL,An adrenergic receptor blocker medication approved for pediatric hypertension treatment,1\n1510,PRAZOSIN,An adrenergic receptor blocker medication approved for pediatric hypertension treatment,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n1540,CAPTOPRIL,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved captopril for pediatric use,13\n1541,FOSINOPRIL,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved fosinopril for pediatric use,13\n1108,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,U.S. FOOD AND DRUG ADMINISTRATION,Both are drug regulatory agencies referenced in the document,12\n1542,AMILORIDE,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved amiloride for pediatric use,12\n1543,CHLORTHALIDONE,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved chlorthalidone for pediatric use,12\n1546,PROPRANOLOL,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved propranolol for pediatric use,12\n1547,ATENOLOL,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved atenolol for pediatric use,12\n1548,PRAZOSIN,NATIONAL MEDICAL PRODUCTS ADMINISTRATION,The NMPA approved prazosin for pediatric use,12\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_6126059b5ea76a2c47fbd668e6fb701f0439414015654fee43c5e8ec2baac29a_v2"}